Prospectus

Nautilus Biotechnology, Inc. Filed 2022-03-02 Acc 0001628280-22-004652

Documents 1

2022-05-03 424B3 Prospectus
2022-03-04 4 CEO, President, and Secretary bought 50,000 shares at $3.60 ($179,890)
2022-03-02 424B3 Prospectus
2022-03-01 EFFECT Notice of Effectiveness
2022-02-25 4 Options or other derivatives
2022-02-25 4 Options or other derivatives
2021-12-21 424B3 Prospectus

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading nautilusmarch2022424b3.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…